Go Pro
→ NASA's ISS Replacement Could Go to This Tiny Space Firm (From Behind the Markets) (Ad)tc pixel Free RX Stock Alerts

BioSyent (RX) Stock Chart & Stock Price History

BioSyent logo
C$16.54 -0.95 (-5.43%)
As of 09/23/2026 03:49 PM Eastern
Compare

BioSyent Stock Price Performance

The BioSyent (RX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 41.37%, with a year-to-date return of 29.93%. In the past month, the stock has increased 6.71%, reflecting recent market activity.

As of the latest close, BioSyent traded at C$16.54 with a market cap of C$187.05 million and volume of 6,686 shares. Five years ago, the stock traded at C$7.25, representing a 128.14% increase over that period. At the time, it had a market cap of C$91.81 million and a volume of 9,848 shares.

Receive RX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+5.15%
1 Month
Performance
+6.71%
3 Month
Performance
+18.14%
Year-To-Date
Performance
+29.93%
1 Year
Performance
+41.37%
5 Year
Performance
+128.14%

RX Stock Chart for Thursday, September, 24, 2026

RX Chart by TradingView

BioSyent Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/23/2026C$17.49C$16.54
-5.43%		C$17.46C$16.336,686 shsC$187.05 million
09/22/2026C$16.00C$17.49
+9.31%		C$17.50C$16.1322,404 shsC$197.79 million
09/21/2026C$15.73C$16.00
+1.72%		C$16.09C$15.803,151 shsC$180.94 million
09/18/2026C$16.06C$15.73
-2.05%		C$16.18C$15.73427 shsC$177.89 million
09/17/2026C$16.08C$16.06
-0.12%		C$16.12C$16.062,673 shsC$181.62 million
09/16/2026C$15.98C$16.08
+0.63%		C$16.08C$15.7099,233 shsC$181.85 million
09/15/2026C$15.85C$15.98
+0.82%		C$15.98C$15.775,000 shsC$180.72 million
09/14/2026C$15.66C$15.85
+1.21%		C$15.98C$15.652,046 shsC$179.25 million
09/11/2026C$15.65C$15.66
+0.06%		C$15.70C$15.564,555 shsC$177.10 million
09/10/2026C$15.69C$15.65
-0.25%		C$15.69C$15.644,430 shsC$176.99 million
09/09/2026C$15.85C$15.69
-1.01%		C$15.85C$15.595,326 shsC$177.44 million
09/08/2026C$15.97C$15.85
-0.75%		C$16.03C$15.852,240 shsC$179.25 million
09/07/2026C$15.97C$15.97C$16.03C$15.874,234 shsC$180.61 million
09/04/2026C$15.88C$15.97
+0.57%		C$16.03C$15.874,234 shsC$180.61 million
09/03/2026C$16.00C$15.88
-0.75%		C$16.04C$15.882,406 shsC$179.59 million
09/02/2026C$15.87C$16.00
+0.82%		C$16.00C$15.87200 shsC$180.94 million
09/01/2026C$15.99C$15.87
-0.75%		C$16.25C$15.827,395 shsC$179.46 million
08/31/2026C$15.75C$15.99
+1.52%		C$16.00C$15.5021,010 shsC$180.82 million
08/28/2026C$15.95C$15.75
-1.25%		C$16.00C$15.7534,658 shsC$178.18 million
08/27/2026C$15.84C$15.95
+0.69%		C$16.00C$15.8910,858 shsC$180.44 million
08/26/2026C$15.70C$15.84
+0.89%		C$15.96C$15.5511,031 shsC$179.20 million
08/25/2026C$15.50C$15.70
+1.29%		C$15.75C$15.595,285 shsC$177.61 million
08/24/2026C$15.70C$15.50
-1.27%		C$15.75C$15.508,349 shsC$175.35 million
Related Companies

This page (CVE:RX) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
My next big call (under $1)
While the Senate was failing to pass the CLARITY Act, the SEC already had its own crypto framework on the tabl...
Crypto 101 Media | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel